Clinical Trial Update: Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab [Phase 2]

View source ↗

Summary

A Phase 2 trial update investigating whether thoraco-mediastinal radiotherapy interacts with maintenance atezolizumab in small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING